CIK 1561743

Kindred Biosciences, Inc.

EDGAR filings

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

84%

VXRT · 3M to 2021-06-30

Named-customer revenue

$3.0M

1 customer · 3M to 2021-06-30

Latest period

Jun 30, 2021

10-Q filed 2021-08-05

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 1

Companies Kindred Biosciences, Inc. discloses as major customers, as a share of Kindred Biosciences, Inc. revenue. 1 active, 0 lapsed.

Company	% of Kindred Biosciences, Inc. revenue	Est. revenue	Period	Trend	Status	Source
VXRT Vaxart, Inc.	84%	$3.0M	3M 2021-06-30	−14.0pp	Active	10-Q 2021-08-05
Vaxart accounted for 84% and 93% of the contract manufacturing services we provided for the three and six months ended June 30, 2021, respectively. 10-Q filed 2021-08-05 Period 3M 2021-04-01 to 2021-06-30 (84%)Accession 0001561743-21-000067 Vaxart accounted for 98% of the contract manufacturing services we provided in the first quarter of 2021. 10-Q filed 2021-05-11 Period 3M 2021-01-01 to 2021-03-31 (98%)Accession 0001561743-21-000036

Unnamed major customers

Disclosed without names in the fiscal year ending 2020-12-31. Identities are not inferred.

Four Distributor Customers78%

Alerts are coming

Get an email when Kindred Biosciences, Inc.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.